Blue Owl Capital Holdings LP 13D and 13G filings for Orchard Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-14 5:05 pm Sale | 2024-09-30 | 13G | Orchard Therapeutics plc ORTX | Blue Owl Capital Holdings LP | 0 0.000% | -15,596,600 (Position Closed) | Filing |
2024-02-14 9:05 pm Purchase | 2023-12-31 | 13G | Orchard Therapeutics plc ORTX | Blue Owl Capital Holdings LP | 15,596,600 6.850% | 15,596,600 (New Position) | Filing |